Davies MJ, Rosenstock J, Ali A, Russell-Jones D, et al. Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin >/=8%, >/=64 mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan-O randomized trial. Diabetes Obes Metab 2021 Oct 6. doi: 10.1111/dom.14543.
PMID: 34617398